کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5814454 1556629 2014 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Beneficial effects of thymosin β4 on spinal cord injury in the rat
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب رفتاری
پیش نمایش صفحه اول مقاله
Beneficial effects of thymosin β4 on spinal cord injury in the rat
چکیده انگلیسی


- Tβ4 treatment makes better motor recovery compared with the saline-treated animals.
- Tβ4 treatment promotes neuronal survival after SCI.
- Tβ4 treatment decreases oligodendrocyte loss and subsequent demyelination after SCI.
- Tβ4 treatment inhibits the early inflammatory response after SCI.
- Tβ4 treatment reduces the area of the lesion cavity in spinal cord after SCI.

Thymosin β4 (Tβ4) has many physiological functions that are highly relevant to spinal cord injury (SCI), including neuronal survival, anti-inflammation, wound repair promotion, and angiogenesis. The present study investigated the therapeutic value of Tβ4 in SCI, with a focus on its neuroprotective, anti-inflammatory, and vasculoprotective properties. Tβ4 or a saline control was administered by intraperitoneal injection 30 min, 3 days, or 5 days after SCI with mild compression in rat. Locomotor recovery was tested with the Basso-Beattie-Bresnahan scale and a footprint analysis. All behavioral assessments were markedly improved with Tβ4 treatment. Histological examination at 7 days post injury showed that the numbers of surviving neurons and oligodendrocytes were significantly increased in Tβ4-treated animals compared to saline-treated controls. Levels of myelin basic protein, a marker of mature oligodendrocytes, in Tβ4-treated rats were 57.8% greater than those in saline-treated controls. The expression of ED1, a marker of activated microglia/macrophages, was reduced by 36.9% in the Tβ4-treated group compared to that of the saline-treated group. Tβ4 treatment after SCI was also associated with a significant decrease in pro-inflammatory cytokine gene expression and a significant increase in the mRNA levels of IL-10 compared to the control. Moreover, the size of lesion cavity delineated by astrocyte scar in the injured spinal cord was markedly reduced in Tβ4-treated animals compared to saline-treated controls. Given the known safety of Tβ4 in clinical trials and its beneficial effects on SCI recovery, the results of this study suggested that Tβ4 is a good candidate for SCI treatment in humans.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuropharmacology - Volume 85, October 2014, Pages 408-416
نویسندگان
, , , , ,